BioInvent International AB (BINV)

Currency in SEK
41.000
+0.650(+1.61%)
Real-time Data·

BINV Financial Summary

Key Ratios

P/E Ratio-5.19
Price/Book3.16
Debt / Equity1.97%
Return on Equity-46.75%
Dividend Yield0.00%
EBITDA-460.01M
Fair ValueUnlock
Fair Value UpsideUnlock

Statements Highlights

Period Ending:
2015
31/12
2016
31/12
2017
31/12
2018
31/12
2019
31/12
2020
31/12
2021
31/12
2022
31/12
2023
31/12
2024
31/12
* In Millions of SEK (except for per share items)

Analyst Ratings

2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 92.500
(+125.61% Upside)

Earnings

Latest Release
Apr 29, 2025
EPS / Forecast
-1.77 / --
Revenue / Forecast
22.06M / --
EPS Revisions
Last 90 days

FAQ

What were BioInvent International's earnings for the latest quarter?

The BioInvent International EPS (TTM) is -7.12. BioInvent International reported sales of 22.06, net income of -116.63, and EPS of -1.77 for the latest quarter.

What was BioInvent International's net income for the latest quarter?

BioInvent International's net income for the latest quarter was -116.63.

How did BioInvent International's performance compare year-over-year in the latest quarter?

The company's revenue moved from 21.37 in the previous quarter to 22.06 in the latest quarter, and net income moved from -116.88 to -116.63 compared to the previous quarter.

What is BioInvent International's net profit margin on a TTM basis?

BioInvent International's trailing twelve months (TTM) net profit margin is -960.87%.

How does BioInvent International's debt to equity ratio compare to industry standards?

BioInvent International's total debt-to-equity ratio is 1.97%.

What is BioInvent International's return on investment on a TTM basis?

BioInvent International's trailing twelve months (TTM) return on investment (ROI) is -46.75%.

Did BioInvent International gain or lose cash last quarter?

In the latest quarter, BioInvent International's net change in cash was 40.44 million.

What were BioInvent International's total assets and liabilities in the latest quarter?

As of the latest quarter, BioInvent International reported total assets of 862.79 million and total liabilities of 87.05 million.

How has BioInvent International's total revenue grown this year?

BioInvent International's total revenue was 21.37 in the previous quarter and 22.06 in the latest quarter.

What is BioInvent International's gross margin on a TTM basis?

BioInvent International's trailing twelve months (TTM) gross margin is 100.00%.

What was BioInvent International's revenue per share for the latest quarter?

BioInvent International's revenue per share for the latest quarter was 0.75.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.